Document Detail


Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa.
MedLine Citation:
PMID:  19360849     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND AIMS: Repeated intravenous antibiotic therapy (IVAT) against chronic pulmonary infection with Pseudomonas aeruginosa is often necessary in cystic fibrosis patients (CF). The aim of this study was to monitor kinetics of degradation of pulmonary and nutritional status after IVAT in CF patients. METHODS: Lung function, nutritional status and physical activity (PA) were measured for 21 CF patients (mean +/- SD age, 16 +/- 1.9 years; 9 boys) who were chronically colonized by P. aeruginosa. Each parameter was measured every 15 days during 3-6 months. RESULTS: Nutritional status as well as PA did not change in the interval of 2 IVAT. In contrary, lung function worsened with a decrease of -14.6% of the FEV(1) (P < 0.05). CONCLUSION: In CF, there is a progressive decrease in lung function without any evident deterioration of nutritional status and PA between two IVAT.
Authors:
Laurent Béghin; Laurent Michaud; Guy-André Loeuille; Nathalie Wizla-Derambure; Hocine Sayah; Anne Sardet; Caroline Thumerelle; Antoine Deschildre; Dominique Turck; Frédéric Gottrand
Related Documents :
10424359 - Repeatability and methodology of resting energy expenditure in patients with cystic fib...
1566109 - Bone changes associated with cystic fibrosis.
10884739 - Retroperitoneal fibrosis: typical and atypical manifestations.
7922929 - Vitamin k and the management of patients with cystic fibrosis.
15633199 - Immunoglobulin and igg subclass levels in a regional pediatric cystic fibrosis clinic.
8129199 - Alcohol and coronary spasm.
12197929 - Anemia and end-stage renal disease in the developing world.
17454929 - Incidence of juvenile idiopathic arthritis in children in estonia: a prospective popula...
11390309 - Cerebral revascularization for cerebral ischemia and stroke prevention in patients with...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pediatric pulmonology     Volume:  44     ISSN:  1099-0496     ISO Abbreviation:  Pediatr. Pulmonol.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-04-27     Completed Date:  2009-08-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8510590     Medline TA:  Pediatr Pulmonol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  464-71     Citation Subset:  IM    
Copyright Information:
(c) 2009 Wiley-Liss, Inc.
Affiliation:
EA 3925, Université Lille 2 Droit et Santé & Division of Gastroenterology, Hepatology and Nutrition, Cystic Fibrosis Center, Lille, France. l-beghin@chru-lille.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Anti-Bacterial Agents / administration & dosage*
Child
Cystic Fibrosis / microbiology,  physiopathology*
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Lung / physiopathology*
Male
Nutritional Status*
Prospective Studies
Pseudomonas Infections / complications,  drug therapy*
Respiratory Function Tests
Respiratory Tract Infections / complications,  drug therapy*,  microbiology
Young Adult
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lower respiratory infections by adenovirus in children. Clinical features and risk factors for bronc...
Next Document:  Increased serum interleukin-5 and vascular endothelial growth factor in children with acute mycoplas...